Clinical Trials Browser

OTHER × Interventional × Meningioma × Clear all

NCT05940493 2026-03-13

Abemaciclib in Newly Diagnosed Meningioma Patients

Phase 2 Recruiting

Meningioma

NCT03971461 2026-03-11

Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

Phase 2 Active not recruiting

Meningioma

NCT06104930 2026-03-10

MOLI

Phase NA Recruiting

Meningioma

NCT05425004 2026-03-05

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Phase 2 Recruiting

Meningioma, Central Nervous System Neoplasms

NCT04298541 2026-02-27

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Phase 2 Not yet recruiting

Meningioma

NCT06377371 2026-02-27

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Phase 4 Recruiting

Meningioma

NCT07428213 2026-02-23

PIVIM

Phase NA Not yet recruiting

Meningioma

NCT06878469 2026-02-19

SIMPLIF-AI

Phase NA Recruiting

Brain Neoplasms, Meningioma

NCT04278118 2026-02-17

HiPPI

Phase NA Recruiting

Brain Neoplasms, Meningioma, Neurilemmoma, Pituitary Neoplasms, Nerve Sheath Neoplasms

NCT06955169 2026-02-17

MOMENTUM-1

Phase 2 Recruiting

Meningioma

NCT05957679 2026-02-12

MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

Phase NA Recruiting

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Meningioma, Neurofibroma, Spinal Cord Neoplasms

NCT06955208 2026-02-12

3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features

Phase NA Recruiting

Tissue Adhesions, Meningioma

NCT06132685 2026-02-10

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

Phase 2 Recruiting

Brain Neoplasms, Meningioma

NCT07398170 2026-02-09

BIOLIMEN-1

Phase NA Not yet recruiting

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

NCT05139277 2026-02-06

Evaluation of the CONVIVO System

Phase NA Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neurilemmoma, Pituitary Neoplasms

NCT06650163 2026-02-05

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Phase 1 Recruiting

Brain Neoplasms, Glioma, Meningioma

NCT02648997 2026-01-26

An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma

Phase 2 Active not recruiting

40 enrolled 14 charts

Meningioma

NCT06012929 2026-01-26

A Study of ONC201 for Refractory Meningioma

Phase 2 Withdrawn

Meningioma

NCT07353229 2026-01-23

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Phase 1 Suspended

Meningioma

NCT03180268 2026-01-14

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Phase 3 Recruiting

Meningioma

NCT04374305 2026-01-12

INTUITT-NF2

Phase 2 Active not recruiting

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT07150806 2025-12-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Phase 1/2 Recruiting

Meningioma

NCT04082520 2025-12-11

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Phase 2 Recruiting

Meningioma

NCT02693990 2025-12-10

A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas

Phase NA Active not recruiting

Brain Neoplasms, Meningioma

NCT04081701 2025-11-21

DOMINO-START

Phase 4 Recruiting

Medulloblastoma, Meningioma, Paraganglioma, Pituitary Neoplasms, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory, Hemangioblastoma

NCT06930846 2025-11-21

HOBSCOTCH-CA

Phase NA Recruiting

Caregiver Burden, Brain Neoplasms, Memory Disorders, Meningioma, Oligodendroglioma, Cognitive Dysfunction

NCT02162732 2025-11-03

Molecular-Guided Therapy for Childhood Cancer

Phase NA Completed

186 enrolled 12 charts

CNSGastrointestinalGenitourinarySarcoma

Carcinoma, Renal Cell, Craniopharyngioma, Ependymoma, Glioma, Carcinoma, Hepatocellular, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Choroid Plexus Neoplasms, Sarcoma, Clear Cell, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT05278208 2025-10-20

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Phase 1/2 Recruiting

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Central Nervous System Neoplasms

NCT06804655 2025-10-02

EViDENCE-BT

Phase 2 Not yet recruiting

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

NCT06439420 2025-10-01

CBT-I in PBT

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Sleep Initiation and Maintenance Disorders, Lymphoma, Meningioma, Oligodendroglioma

NCT06831461 2025-09-16

PRIDE

Phase NA Recruiting

Brain Neoplasms, Meningioma, Pituitary Neoplasms

NCT06632860 2025-07-09

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors

Phase EARLY_PHASE1 Recruiting

Meningioma

NCT01892397 2025-07-02

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

Phase NA Active not recruiting

Brain Neoplasms, Meningioma

NCT06036706 2025-06-24

CANCER-COG

Phase NA Recruiting

Meningioma, Radiation Injuries

NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Phase 2 Completed

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT05416567 2025-06-05

e-men

Phase NA Recruiting

Brain Neoplasms, Meningioma

NCT06014905 2025-05-25

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

Phase 1 Recruiting

Meningioma

NCT01324635 2025-05-02

Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors

Phase 1 Terminated

Brain Neoplasms, Glioma, Meningioma

NCT03095248 2025-04-22

SEL-TH-1601

Phase 2 Terminated

10 enrolled 9 charts

Ependymoma, Glioma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT06937268 2025-04-22

DOTATATE-RT

Phase NA Not yet recruiting

Meningioma

NCT04659811 2025-04-17

Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

Phase 2 Recruiting

Meningioma

NCT04997317 2025-04-13

PROMENADE

Phase 1/2 Recruiting

Meningioma, Neoplasms

NCT05793034 2025-03-13

23Men

Phase NA Recruiting

Meningioma

NCT06275919 2025-03-13

MIRAGE

Phase 2 Recruiting

Meningioma

NCT06126588 2025-03-11

ELUMEN

Phase 2 Recruiting

Meningioma

NCT04595786 2025-03-04

STAMP

Phase NA Completed

Meningioma, Seizures

NCT03016091 2025-02-18

A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma

Phase 2 Terminated

18 enrolled 9 charts

Hemangiopericytoma, Meningioma

NCT06830356 2025-02-17

SPIDER-MEN

Phase NA Recruiting

Meningioma

NCT06710249 2025-01-27

AFBTEdema

Phase 2 Recruiting

Brain Edema, Glioblastoma, Meningioma

NCT06787807 2025-01-22

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Phase NA Not yet recruiting

BreastCNSGastrointestinalGenitourinaryGynecologicHead & NeckOtherPlasma cell

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Kidney Neoplasms, Liver Neoplasms, Meningioma, Multiple Myeloma, Neoplasms, Obesity, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms